bell
The current prices are delayed by 15 mins, login to check live prices.
Nectar Lifescience Ltd share price logo

Nectar Lifescience Ltd Share Price

(NECLIFE)

₹40.9▲1.36%

as on 04:01PM, 20 Jan 2025

Overview
News
Financials
Q3 2024 Results
Technicals

Nectar Lifescience Ltd Performance

  • Day's Low

    Day's High

    ₹39.56
    Day's Price Range
    ₹41

  • 52 Week's Low

    52 Week's High

    ₹26.15
    52-Week Price Range
    ₹56.5
1 Month Return-3.47 %
3 Month Return+ 10.34 %
1 Year Return+ 19.56 %
Previous Close₹40.35
Open₹40.90
Volume6.59L
Upper Circuit-
Lower Circuit-
Market Cap₹904.89Cr

Nectar Lifescience Ltd Key Statistics

P/E Ratio84.06
PEG Ratio140.1
Market Cap₹904.89 Cr
P/B Ratio0.63
EPS0.22
Dividend Yield0
SectorPharmaceuticals
ROE0.47

Nectar Lifescience Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Nectar Lifescience Ltd
Nectar Lifescience Ltd
NA₹904.89 Cr35.09%0.69₹5 Cr₹1,684 Cr
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd
NA₹887.14 Cr244.49%0.62₹28 Cr₹125 Cr
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd
NA₹75.29 Cr11.76%0.78₹2 Cr₹45 Cr
Chemo Pharma Laboratories Ltd
Chemo Pharma Laboratories Ltd
NA₹14.25 Cr233.33%0.50NANA
Ortin Global Ltd
Ortin Global Ltd
NA₹13.61 Cr15.24%0.69NANA
See all

About Nectar Lifescience Ltd

Nectar Lifesciences Ltd (NLL or NECLIFE) is a globally acclaimed integrated pharmaceutical organization engaged in the manufacture and supply of high quality pharmaceutical products. With a vast network of production sites spread across three Indian states of Punjab, Himachal Pradesh, and Jammu, the organization provides top-notch active pharmaceutical ingredients (API), finished dosage forms, phytochemicals, and hard gelatin capsules to customers in over 90 countries across the world. In addition to manufacturing and marketing cephalosporins and phytochemicals, NECLIFE is also into contract manufacturing of APIs. Established in 1995, the organization has seen a number of expansions, the most recent being in 2019 when they established a unit in Portugal to take over marketing activities from the UK-based wing. They have also launched two new innovative products in the form of menthol capsules and pearl capsules. Focussing on providing quality products, NECLIFE has obtained approval from the Japanese MOH and is well-poised to continue its phenomenal rise in the global pharmaceuticals market.

Share Price: ₹40.90 per share as on 20 Jan, 2025 04:01 PM
Market Capitalisation: ₹904.89Cr as of today
Revenue: ₹427.88Cr as on September 2024 (Q3 24)
Net Profit: ₹5.60Cr as on September 2024 (Q3 24)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
OrganisationNectar Lifescience Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Nectar Lifescience Ltd

  • Nectar Lifescience Reports Strong Q3 Growth - 28 Nov, 2024

    Nectar Lifescience reported a 7.57% increase in net sales to Rs 428.10 crore for September 2024, with net profit soaring 451.45% to Rs 5.60 crore. EBITDA rose 17.48%, and EPS increased to Rs 0.25. The stock has shown stable performance with 8.20% returns over the last year.

  • Nectar Lifescience Reports Strong Q3 Growth - 26 Nov, 2024

    Nectar Lifescience's standalone net sales for September 2024 reached Rs 428.10 crore, up 7.57% YoY. Net profit surged 451.45% to Rs 5.60 crore, with EBITDA rising 17.48%. EPS increased to Rs 0.25 from Rs 0.05. Shares closed at Rs 32.95 on November 25, 2024.

  • Nectar Lifesciences Faces ITC Discrepancy Challenge - 21 Nov, 2024

    Nectar Lifesciences is facing a challenge regarding a ₹1.01 crore discrepancy in Input Tax Credit (ITC) for FY 2021-22. The Asst. Commissioner ruled that the company availed excess ITC, which is deemed ineligible. The company plans to appeal the decision.

Insights on Nectar Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 359.85 Cr → 428.79 Cr (in ₹), with an average increase of 16.1% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 44.35% to 44.53% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 32.54% to 54.72% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, NECLIFE stock has moved up by 27.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 0.59 Cr → 5.6 Cr (in ₹), with an average increase of 63.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 37.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 80.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.57% to 0.73% in Dec 2024 quarter

Nectar Lifescience Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹397.96Cr (-)₹452.16Cr (↑13.62%)₹439.85Cr (↓2.72%)₹358.85Cr (↓18.42%)₹427.88Cr (↑19.24%)
Net Income₹1.02Cr (-)₹1.57Cr (↑53.92%)₹0.59Cr (↓62.42%)₹2.97Cr (↑403.39%)₹5.60Cr (↑88.55%)
Net Profit Margin0.26% (-)0.35% (↑34.62%)0.13% (↓62.86%)0.83% (↑538.46%)1.31% (↑57.83%)
Value in ₹ crore
Details2021202220232024
Total Assets₹2,514.45Cr (-)₹2,520.35Cr (↑0.23%)₹2,323.80Cr (↓7.80%)₹2,324.02Cr (↑0.01%)
Total Liabilities₹1,453.71Cr (-)₹1,433.48Cr (↓1.39%)₹1,259.20Cr (↓12.16%)₹1,254.76Cr (↓0.35%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹285.65Cr (-)₹21.33Cr (↓92.53%)₹95.04Cr (↑345.57%)₹133.37Cr (↑40.33%)₹224.69Cr (↑68.47%)

Nectar Lifescience Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
44.53%
0.40
Foreign Institutions
0.73%
-71.56
Mutual Funds
0%
0.00
Retail Investors
54.72%
68.14
Others
0.02%
-99.90

Nectar Lifescience Ltd Key Indicators

Details20202021202220232024
Return On Equity %2.68-4.351.48-5.850.47
Details20202021202220232024
Return On Assets %1.2-2.910.99-1.040.22
Details20202021202220232024
Book Value Per Share (₹)50.6647.3648.5147.4747.68
Details20202021202220232024
Earning Per Share (₹)1.42-3.271.12-1.080.22

Nectar Lifescience Ltd Valuation

Nectar Lifescience Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-284.58x)

December 21, 2023

Industry (54.95x)

January 17, 2025

Today (84.06x)

January 17, 2025

Highest (403.33x)

August 26, 2020

LowHigh

Nectar Lifescience Ltd Earnings and Dividends

  • Nectar Lifescience Ltd Earnings Results

    Nectar Lifescience Ltd’s net profit jumped 449.02% since last year same period to ₹5.60Cr in the Q2 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 88.55% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Nectar Lifescience Ltd Dividends July,2020

    In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.12%.

    Read More about Dividends

Nectar Lifescience Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Nectar Lifescience Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Nectar Lifescience Ltd

Nectar Lifescience Ltd share price today stands at ₹40.9, Open. ₹40.9 ; Previous Close. ₹40.35 ; High. ₹41 ; Low. ₹39.56 ; 52 Week High. ₹56.5 ; 52 Week Low: ₹26.15.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Nectar Lifescience Ltd shares.

Nectar Lifescience Ltd is listed on NSE

Nectar Lifescience Ltd is listed on BSE

  • Today’s highest price of Nectar Lifescience Ltd is ₹41.
  • Today’s lowest price of Nectar Lifescience Ltd is ₹39.56.

PE Ratio of Nectar Lifescience Ltd is 84.06

PE ratio = Nectar Lifescience Ltd Market price per share / Nectar Lifescience Ltd Earnings per share

Today’s traded volume of Nectar Lifescience Ltd(NECLIFE) is 6.59L.

Today’s market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹904.89Cr.

Nectar Lifescience Ltd(NECLIFEPrice
52 Week High
₹56.5
52 Week Low
₹26.15

Nectar Lifescience Ltd(NECLIFE) share price is ₹40.9. It is down -27.61% from its 52 Week High price of ₹56.5

Nectar Lifescience Ltd(NECLIFE) share price is ₹40.9. It is up 56.41% from its 52 Week Low price of ₹26.15

Nectar Lifescience Ltd(NECLIFEReturns
1 Day Returns
0.55%
1 Month Returns
-3.47%
3 Month Returns
10.34%
1 Year Returns
19.56%